Kalshi launches prediction markets for clinical trials and FDA approvals
Kalshi, one of the world's largest prediction market exchanges, has announced it will start taking bets on clinical trial outcomes and FDA regulatory approvals. The platform partnered with AppliedXL, a tech company that monitors and predicts clinical trial results, to select an initial small number of markets. The move extends prediction markets into the biopharma sector after earlier expansions into sports, politics and reality TV.
Comments
No comments yet
Comments
No comments yet โ be the first to weigh in ๐
No comments yet. Be the first!